awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35999644-BF70E771-7A4F-4514-8620-DC0F675BA685
Q35999644-BF70E771-7A4F-4514-8620-DC0F675BA685
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35999644-BF70E771-7A4F-4514-8620-DC0F675BA685
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.
P2860
Q35999644-BF70E771-7A4F-4514-8620-DC0F675BA685
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35999644-BF70E771-7A4F-4514-8620-DC0F675BA685
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
097cc7f7a873fbdfb4afa7b6398701ec62da7a52
P2860
cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?